{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T12:46:15Z","timestamp":1777898775664,"version":"3.51.4"},"reference-count":15,"publisher":"SAGE Publications","issue":"2","license":[{"start":{"date-parts":[[2025,11,23]],"date-time":"2025-11-23T00:00:00Z","timestamp":1763856000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"funder":[{"DOI":"10.13039\/100021704","name":"Administration for Strategic Preparedness and Response","doi-asserted-by":"publisher","award":["U3REP220682"],"award-info":[{"award-number":["U3REP220682"]}],"id":[{"id":"10.13039\/100021704","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Public Health Rep"],"published-print":{"date-parts":[[2026,3]]},"abstract":"<jats:p>\n                    We investigated the proportion of mpox hospitalizations for medical indications versus infection control isolation at New York University Langone Health and NYC Health + Hospitals from May 1, 2022, through April 28, 2023. We reviewed the electronic medical records of people with a positive mpox nucleic acid amplification test independently. We collected demographic and clinical data on those who met our inclusion criteria, and we stratified patients by medical indication or infection control isolation based on their reason for hospitalization. This observational cohort study included 66 patients admitted for mpox, of whom 8 (12.1%) were admitted primarily for infection control isolation and 58 (87.9%) were admitted primarily for medical indications. Those hospitalized primarily for isolation (vs medical indications) were significantly less likely to have a private residence (25.0% vs 79.3%;\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    &lt; .001). Those hospitalized for medical indications (vs isolation) were significantly more likely to be HIV positive (63.8% vs 12.5%;\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    = .006), to have secondary bacterial infections (65.5% vs 25.0%;\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    = .03), and to receive antibiotics (81.0% vs 25.0%;\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    &lt; .001). We found no significant differences in the median cumulative length of stay per patient or the proportion of tecovirimat receipt between the 2 groups. While the small size of the isolation cohort was a limitation of this analysis, our findings argue for increased capacity for community-based isolation, which may reduce the use of hospital admissions primarily for infection control isolation in future outbreaks.\n                  <\/jats:p>","DOI":"10.1177\/00333549251385983","type":"journal-article","created":{"date-parts":[[2025,11,24]],"date-time":"2025-11-24T06:14:13Z","timestamp":1763964853000},"page":"196-200","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":0,"title":["Characteristics of Inpatient Admission for Mpox Infection Control Isolation at 2 Large New York City Health Systems, 2022-2023"],"prefix":"10.1177","volume":"141","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1284-6428","authenticated-orcid":false,"given":"Madeline A.","family":"DiLorenzo","sequence":"first","affiliation":[{"name":"Division of Infectious Diseases and Immunology, Department of Medicine, New York University Grossman School of Medicine, New York, NY, USA"},{"name":"Division of Infectious Diseases and Immunology, Department of Medicine, New York City Health + Hospitals\/Bellevue, New York, NY, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anthony","family":"Lo Piccolo","sequence":"additional","affiliation":[{"name":"Special Pathogens Program, NYC Health + Hospitals\/Bellevue, New York, NY, USA"},{"name":"Division of Pulmonary, Critical Care, and Sleep Medicine, Department of Medicine, New York University Grossman School of Medicine, New York, NY, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David Scott","family":"Butler","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases and Immunology, Department of Medicine, New York University Grossman School of Medicine, New York, NY, USA"},{"name":"Division of Infectious Diseases and Immunology, Department of Medicine, New York City Health + Hospitals\/Bellevue, New York, NY, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kathryn","family":"Jano","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases and Immunology, Department of Medicine, New York University Grossman School of Medicine, New York, NY, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angelie","family":"Oberoi","sequence":"additional","affiliation":[{"name":"Data and Analytics, NYC Health + Hospitals, New York, NY, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aakib","family":"Mansuri","sequence":"additional","affiliation":[{"name":"Data and Analytics, NYC Health + Hospitals, New York, NY, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mikhail","family":"Nauth","sequence":"additional","affiliation":[{"name":"Data and Analytics, NYC Health + Hospitals, New York, NY, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simona","family":"Bratu","sequence":"additional","affiliation":[{"name":"Infectious Diseases\/HIV Clinic, NYC Health + Hospitals\/Harlem, New York, NY, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeanne Sullivan","family":"Meissner","sequence":"additional","affiliation":[{"name":"New York City Department of Health and Mental Hygiene, New York, NY, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mary M.K.","family":"Foote","sequence":"additional","affiliation":[{"name":"New York City Department of Health and Mental Hygiene, New York, NY, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vikramjit","family":"Mukherjee","sequence":"additional","affiliation":[{"name":"Special Pathogens Program, NYC Health + Hospitals\/Bellevue, New York, NY, USA"},{"name":"Division of Pulmonary, Critical Care, and Sleep Medicine, Department of Medicine, New York University Grossman School of Medicine, New York, NY, USA"},{"name":"Medical Intensive Care Unit, NYC Health + Hospitals\/Bellevue, New York, NY, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Radu","family":"Postelnicu","sequence":"additional","affiliation":[{"name":"Special Pathogens Program, NYC Health + Hospitals\/Bellevue, New York, NY, USA"},{"name":"Division of Pulmonary, Critical Care, and Sleep Medicine, Department of Medicine, New York University Grossman School of Medicine, New York, NY, USA"},{"name":"Medical Intensive Care Unit, NYC Health + Hospitals\/Bellevue, New York, NY, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0056-8224","authenticated-orcid":false,"given":"Justin","family":"Chan","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases and Immunology, Department of Medicine, New York University Grossman School of Medicine, New York, NY, USA"},{"name":"Division of Infectious Diseases and Immunology, Department of Medicine, New York City Health + Hospitals\/Bellevue, New York, NY, USA"},{"name":"Special Pathogens Program, NYC Health + Hospitals\/Bellevue, New York, NY, USA"},{"name":"Infection Prevention and Control, NYC Health + Hospitals\/Bellevue, New York, NY, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","published-online":{"date-parts":[[2025,11,23]]},"reference":[{"key":"e_1_3_2_2_2","unstructured":"World Health Organization. 2022-2024 Mpox (monkeypox) outbreak: global trends. January 8 2025. Accessed January 14 2025. https:\/\/worldhealthorg.shinyapps.io\/mpx_global\/#4_Global_situation_update"},{"key":"e_1_3_2_3_2","unstructured":"Centers for Disease Control and Prevention. Mpox 2022-2023 U.S. map and case count. Accessed August 5 2024. https:\/\/www.cdc.gov\/poxvirus\/mpox\/response\/2022\/us-map.html"},{"key":"e_1_3_2_4_2","unstructured":"New York City Department of Health. Mpox. 2024. Accessed August 6 2024. https:\/\/www.nyc.gov\/site\/doh\/health\/health-topics\/mpox.page"},{"key":"e_1_3_2_5_2","doi-asserted-by":"publisher","DOI":"10.1177\/20499361231196683"},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciad482"},{"key":"e_1_3_2_7_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2207323"},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(22)02187-0"},{"key":"e_1_3_2_9_2","unstructured":"Centers for Diseases Control and Prevention. Mpox infection prevention and control in healthcare settings. September 13 2024. Accessed August 5 2024. https:\/\/www.cdc.gov\/poxvirus\/mpox\/clinicians\/infection-control-healthcare.html"},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(22)00228-6"},{"key":"e_1_3_2_11_2","unstructured":"HIV.gov. Guidelines for the prevention and treatment of opportunistic infections in adults and adolescents with HIV. 2024. Accessed August 6 2024. https:\/\/clinicalinfo.hiv.gov\/en\/guidelines\/hiv-clinical-guidelines-adult-and-adolescent-opportunistic-infections\/whats-new"},{"key":"e_1_3_2_12_2","unstructured":"Centers for Disease Control and Prevention. Tecovirimat (TPOXX) for treatment of mpox. December 10 2024. Accessed January 8 2025. https:\/\/www.cdc.gov\/mpox\/hcp\/clinical-care\/tecovirimat.html?CDC_AAref_Val="},{"key":"e_1_3_2_13_2","unstructured":"Kaiser Family Foundation. Hospital adjusted expenses per inpatient day 1999-2022. 2022. Accessed August 6 2024. https:\/\/www.kff.org\/health-costs\/state-indicator\/expenses-per-inpatient-day"},{"key":"e_1_3_2_14_2","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2021.0490"},{"key":"e_1_3_2_15_2","doi-asserted-by":"publisher","DOI":"10.1089\/hs.2022.0120"},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.1177\/1357633X231194796"}],"container-title":["Public Health Reports\u00ae"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/00333549251385983","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/00333549251385983","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/00333549251385983","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T09:40:42Z","timestamp":1777628442000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/00333549251385983"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,23]]},"references-count":15,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["10.1177\/00333549251385983"],"URL":"https:\/\/doi.org\/10.1177\/00333549251385983","relation":{},"ISSN":["0033-3549","1468-2877"],"issn-type":[{"value":"0033-3549","type":"print"},{"value":"1468-2877","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,23]]}}}